John Mendlein

Affiliations

  • at Fate Therapeutics Inc (FATE), 2025-05-30
  • at Omega Therapeutics Inc. (OMGA), 2024-06-21
  • Director at Atyr Pharma Inc (LIFE), 2019-05-10
  • See Remarks at Moderna Inc. (MRNA), 2018-12-07
  • Director at Editas Medicine Inc. (EDIT), 2017-06-19
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
FATE $5.43 36,631 $198,906.33 282,770 2023-01-13 Filing
FATE $5.67 88,048 $499,232.16 246,139 2023-01-11 Filing
LIFE $0.42 195,000 $82,602.00 615,382 2018-12-21 Filing
LIFE $0.41 50,000 $20,645.00 420,382 2018-12-20 Filing
LIFE $2.65 37,736 $100,000.40 367,883 2017-08-31 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
FATE $22.79 1,364 $31,085.56 158,091 2022-06-03 Filing
FATE $35.48 12,069 $428,208.12 159,455 2022-03-10 Filing
FATE $34.73 19,493 $676,991.89 171,524 2022-03-10 Filing